Alembic Pharma Profit Jumps 81 Percent on US Sales
Alembic Pharmaceuticals reported an 81 percent rise in second quarter profit driven by strong sales in the United States market. Consolidated profit reached 3.35 billion rupees while revenue from operations increased more than 36 percent.
Xurve View
Insights:
Xurve View
Alembic Pharmaceuticals Ltd posted an 81% profit rise to 3.35 billion rupees ($35.37M) in the second quarter on Wednesday morning, driven by strong growth in United States sales. The earnings beat expectations and sent the company's shares surging 20% on the session. India's pharmaceutical sector continues to benefit from robust international generics demand.
